FDA.reportPublic FDA data

Gold Bond Psoriasis Relief Cream

Manufacturer
Gold Bond Co LLC
Effective date
2025-12-04
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:19:51

Label at a glance#

ProductGold Bond Psoriasis Relief Medicated Multi-Symptom
Active ingredientSALICYLIC ACID
Label structure8 sections

Indications and uses

For relief of skin itching, irritation, redness, flaking and scaling associated with psoriasis and/or seborrheic dermatitis, and to help prevent symptom recurrence

Dosage and administration

Apply to affected areas one to four times daily or as directed by a doctor

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Gold Bond Psoriasis Relief Medicated Multi-Symptom Cream

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 3%

Purposes

OTC - PURPOSE SECTION

Psoriasis, Seborrheic Dermatitis

Uses

INDICATIONS & USAGE SECTION

For relief of skin itching, irritation, redness, flaking and scaling associated with psoriasis and/or seborrheic dermatitis, and to help prevent symptom recurrence

Warnings

WARNINGS SECTION

For external use only

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

  • condition covers a large area of the body

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • condition worsens or does not improve after regular use of this product as directed

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply to affected areas one to four times daily or as directed by a doctor

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, hydroxyethyl urea, petrolatum, aminomethyl propanol, glycerin, dimethicone, gluconolactone, steareth-21, jojoba esters, glyceryl stearate, stearyl alcohol, aloe barbadensis leaf juice, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, butyrospermum parkii (shea) butter extract, methyl gluceth-20, 7-dehydrocholesterol, bisabolol, ceteareth-25, zea mays (corn) oil, zingiber officinale (ginger) root extract, ceramide NP, hydrolyzed jojoba esters, cetearyl alcohol, stearamidopropyl PG-dimonium chloride phosphate, magnesium ascorbyl phosphate, panthenol, tocopheryl acetate, ceramide EOP, pentylene glycol, ceramide EOS, bis-lauryl cocaminopropylamine/HDI/PEG-100 copolymer, cholesterol, propylene glycol, caprooyl phytosphingosine, polysorbate 60, ceramide NS, cetyl alcohol, isohexadecane, ethylhexylglycerin, 4-t-butylcyclohexanol, ceramide AP, EDTA, behenic acid, butylene glycol, caprooyl sphingosine, methylparaben, tocopherol

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Gold Bond Psoriasis Relief Medicated Multi-Symptom Cream
Net wt 4 oz (113 g)

PRINCIPAL DISPLAY PANEL Gold Bond Psoriasis Relief Medicated Multi-Symptom Cream Net wt 4 oz (113 g)PRINCIPAL DISPLAY PANEL Gold Bond Psoriasis Relief Medicated Multi-Symptom Cream Net wt 4 oz (113 g)

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
416910salicylic acid 3 % Topical CreamPSN1
416910salicylic acid 30 MG/ML Topical CreamSCD1
416910salicylic acid 3 % Topical CreamSY1

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeData Matrix921354gold-bond-psoriasis-relief-cream-01.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84714-0413-2Gold Bond Psoriasis Relief Medicated Multi-Symptom113 g in 1 TUBECREAM1131

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 47 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84714-041384714-0413-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 46 matching rows.

Name, UNII, Kind table
NameUNIIKind
SALICYLIC ACIDO414PZ4LPZACTIB
WATER059QF0KO0RIACT
HYDROXYETHYL UREAMBQ7DDQ7ARIACT
PETROLATUM4T6H12BN9UIACT
AMINOMETHYLPROPANOLLU49E6626QIACT
GLYCERINPDC6A3C0OXIACT
DIMETHICONE92RU3N3Y1OIACT
GLUCONOLACTONEWQ29KQ9POTIACT
STEARETH-2153J3F32P58IACT
HYDROGENATED JOJOBA OIL, RANDOMIZEDQ47ST02F58IACT
GLYCERYL STEARATE230OU9XXE4IACT
STEARYL ALCOHOL2KR89I4H1YIACT
ALOE VERA LEAFZY81Z83H0XIACT
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)86FQE96TZ4IACT
SHEA BUTTERK49155WL9YIACT
METHYL GLUCETH-20J3QD0LD11PIACT
7-DEHYDROCHOLESTEROLBK1IU07GKFIACT
LEVOMENOL24WE03BX2TIACT
CETEARETH-258FA93U5T67IACT
CORN OIL8470G57WFMIACT
GINGERC5529G5JPQIACT
CERAMIDE NP4370DF050BIACT
HYDROLYZED JOJOBA ESTERS (ACID FORM)UDR641JW8WIACT
CETEARYL ALCOHOL2DMT128M1SIACT
STEARAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATEW6000VEI5YIACT
MAGNESIUM ASCORBYL PHOSPHATE0R822556M5IACT
PANTHENOLWV9CM0O67ZIACT
ALPHA-TOCOPHEROL ACETATE9E8X80D2L0IACT
PENTYLENE GLYCOL50C1307PZGIACT
CERAMIDE EOSCR0J8RN66KIACT
CHOLESTEROL97C5T2UQ7JIACT
PROPYLENE GLYCOL6DC9Q167V3IACT
CAPROOYL PHYTOSPHINGOSINE2FD4Y5XL2LIACT
POLYSORBATE 60CAL22UVI4MIACT
CERAMIDE NSV7M2259XJMIACT
CETYL ALCOHOL936JST6JCNIACT
ISOHEXADECANE918X1OUF1EIACT
ETHYLHEXYLGLYCERIN147D247K3PIACT
4-T-BUTYLCYCLOHEXANOLK0H1405S9CIACT
CERAMIDE APF1X8L2B00JIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Gold Bond Psoriasis Relief Medicated Multi-SymptomSALICYLIC ACIDGold Bond Co LLC5949a2e4-9169-4fca-aabb-b18dd1bc298b2025-12-04WarningsExact identifier
ndc (package): 84714-0413-2
ndc (product): 84714-0413
ndc11 (package): 84714041302
spl id: 83bb43c7-35b4-4e8f-ae75-9495e801df42
spl set id: 5949a2e4-9169-4fca-aabb-b18dd1bc298b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.